Robot vs. standard surgery: which is safer for Women's cancers?
NCT ID NCT01247779
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 386 women with cervical, uterine, or ovarian cancer to compare standard laparoscopic surgery versus robot-assisted laparoscopic surgery. The goal was to see which approach causes fewer complications within six months after the operation. Researchers tracked side effects, pain control, and surgeon comfort to help guide future surgical choices.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors choose the safer surgical method for women with gynecologic cancers.
What could go wrong
This is an observational comparison, not a treatment test. Results may not apply to all patients or hospitals.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHRU Lille, Hôpital Jeanne de Flandres
Lille, 59037, France
-
CHRU de Tours
Tours, 37044, France
-
CHU Bordeaux, Hôpital Saint-André
Bordeaux, 33300, France
-
CHU Limoges
Limoges, 87042, France
-
CHU Nîmes
Nîmes, 30029, France
-
CHU Rangueil
Toulouse, 31059, France
-
Centre Alexis Vautrin
Vandœuvre-lès-Nancy, 54511, France
-
Centre Hospitalier de Valenciennes
Valenciennes, 59322, France
-
Centre Oscar Lambret
Lille, 59000, France
-
Centre hospitalier de Roubaix
Roubaix, 59056, France
-
Hôpital Européen Georges Pompidou
Paris, 75015, France
-
Institut Claudius Regaud
Toulouse, 31052, France
-
Institut Paoli Calmette
Marseille, 13009, France
-
Institut de Cancérologie de l'Ouest Site René Gauducheau
Saint-Herblain, 44805, France
-
Polyclinique Bordeaux Nord Aquitaine
Bordeaux, 33300, France
-
Polyclinique Courlancy
Reims, 51100, France
-
Polyclinique KenVal
Nîmes, 30900, France